Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
States
/
Oklahoma

Product Recalls in Oklahoma

All product recalls affecting Oklahoma.

Includes nationwide recalls (tagged “Nationwide”) and recalls with Oklahoma in the distribution area.

Get alerts for Oklahoma

Showing 3101–3120 of 33850 recalls

BD Vision Climbing Harness – Fall Hazard (2025)

This recall involves all BD Vision Harnesses. This lightweight harness is designed for technical alpine and ice climbs. All sizes are included in this recall. The harness has fixed leg loops and was sold in black and white colors. "Black Diamond" is printed on one of the leg loops. "Vision" is printed on the other leg loop.

Very High

CPSCMar 13, 2025Nationwide

Diltiazem Extended-Release Capsules (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Stay Informed

Product Recalls in Oklahoma

BD Vision Climbing Harness – Fall Hazard (2025)

Diltiazem Extended-Release Capsules (Glenmark) – CGMP Deviations (2025)

Levetiracetam Injection (Dr. Reddy's) – Labeling Error (2025)

Propafenone Extended-Release Capsules (Glenmark) – CGMP Deviations (2025)

Pravastatin Sodium Tablets (Glenmark) – CGMP Deviations (2025)

Fluphenazine Tablets (Glenmark) – CGMP Deviations (2025)

Fenofibrate Capsules (Glenmark) – CGMP Deviations (2025)

Cetirizine Hydrochloride Tablets 10mg (Glenmark) – CGMP Issues (2025)

Rufinamide Tablets 200mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 150mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 100mg (Glenmark) – CGMP Issues (2025)

Carvedilol Tablets 12.5mg (Glenmark) – CGMP Issues (2025)

Propafenone Extended-Release 225mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 200mg (Glenmark) – CGMP Issues (2025)

Clindamycin Hydrochloride Capsules 300mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 50mg (Glenmark) – CGMP Issues (2025)

Propafenone Extended-Release 225mg (Glenmark) – CGMP Issues (2025)

Voriconazole Tablets 200mg (Glenmark) – CGMP Deviations (2025)

Fluphenazine Hydrochloride Tablets 2.5mg (Glenmark) – CGMP Deviations (2025)

Propafenone Extended-Release 325mg (Glenmark) – CGMP Issues (2025)

Other States